144 related articles for article (PubMed ID: 24767691)
1. [The threat of the carbapenemase-producing enterobacteriaceae in Spain: positioning report of the SEIMC study groups, GEIH and GEMARA].
Oteo J; Calbo E; Rodríguez-Baño J; Oliver A; Hornero A; Ruiz-Garbajosa P; Horcajada JP; Del Pozo JL; Riera M; Sierra R; Bou G; Salavert M
Enferm Infecc Microbiol Clin; 2014 Dec; 32(10):666-70. PubMed ID: 24767691
[TBL] [Abstract][Full Text] [Related]
2. Carbapenemase-producing Enterobacteriaceae: the end of the antibiotic era?
Pascual Á; Pintado V; Rodríguez-Baño J; Miró JM
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():1-3. PubMed ID: 25542045
[TBL] [Abstract][Full Text] [Related]
3. Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: what should be expected in the future?
Oteo J; Miró E; Pérez-Vázquez M; Navarro F
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():17-23. PubMed ID: 25542048
[TBL] [Abstract][Full Text] [Related]
4. Prospective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem.
Oteo J; Ortega A; Bartolomé R; Bou G; Conejo C; Fernández-Martínez M; González-López JJ; Martínez-García L; Martínez-Martínez L; Merino M; Miró E; Mora M; Navarro F; Oliver A; Pascual Á; Rodríguez-Baño J; Ruiz-Carrascoso G; Ruiz-Garbajosa P; Zamorano L; Bautista V; Pérez-Vázquez M; Campos J;
Antimicrob Agents Chemother; 2015; 59(6):3406-12. PubMed ID: 25824224
[TBL] [Abstract][Full Text] [Related]
5. Treatment of infections caused by carbapenemase-producing Enterobacteriaceae.
Rodríguez-Baño J; Cisneros JM; Gudiol C; Martínez JA
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():49-55. PubMed ID: 25542052
[TBL] [Abstract][Full Text] [Related]
6. Carbapenemase-producing Enterobacteriaceae in a tertiary hospital in Madrid, Spain: high percentage of colistin resistance among VIM-1-producing Klebsiella pneumoniae ST11 isolates.
Pena I; Picazo JJ; Rodríguez-Avial C; Rodríguez-Avial I
Int J Antimicrob Agents; 2014 May; 43(5):460-4. PubMed ID: 24657043
[TBL] [Abstract][Full Text] [Related]
7. Notes from the Field: Carbapenem-resistant Enterobacteriaceae Producing OXA-48-like Carbapenemases--United States, 2010-2015.
Lyman M; Walters M; Lonsway D; Rasheed K; Limbago B; Kallen A
MMWR Morb Mortal Wkly Rep; 2015 Dec; 64(47):1315-6. PubMed ID: 26633574
[TBL] [Abstract][Full Text] [Related]
8. Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge.
Nordmann P
Med Mal Infect; 2014 Feb; 44(2):51-6. PubMed ID: 24360201
[TBL] [Abstract][Full Text] [Related]
9. Global dissemination of extensively drug-resistant carbapenemase-producing Enterobacteriaceae: clinical perspectives on detection, treatment and infection control.
Tängdén T; Giske CG
J Intern Med; 2015 May; 277(5):501-12. PubMed ID: 25556628
[TBL] [Abstract][Full Text] [Related]
10. [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].
Stock I
Med Monatsschr Pharm; 2014 May; 37(5):162-72; quiz 173-4. PubMed ID: 24908928
[TBL] [Abstract][Full Text] [Related]
11. Description of carbapenemase-producing Enterobacteriaceae isolates in a Spanish tertiary hospital. Epidemiological analysis and clinical impact.
López-González L; Viñuela-Prieto JM; Rodriguez-Avial I; Manzano R; Candel FJ
Rev Esp Quimioter; 2019 Jun; 32(3):254-262. PubMed ID: 30968674
[TBL] [Abstract][Full Text] [Related]
12. Carbapenemase-producing Enterobacteriaceae: a call for action!
Nordmann P; Cornaglia G
Clin Microbiol Infect; 2012 May; 18(5):411-2. PubMed ID: 22507108
[No Abstract] [Full Text] [Related]
13. A single-day point-prevalence study of faecal carriers in long-term care hospitals in Madrid (Spain) depicts a complex clonal and polyclonal dissemination of carbapenemase-producing Enterobacteriaceae.
Ruiz-Garbajosa P; Hernández-García M; Beatobe L; Tato M; Méndez MI; Grandal M; Aranzábal L; Alonso S; Lópaz MÁ; Astray J; Cantón R
J Antimicrob Chemother; 2016 Feb; 71(2):348-52. PubMed ID: 26518051
[TBL] [Abstract][Full Text] [Related]
14. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004).
Deshpande LM; Jones RN; Fritsche TR; Sader HS
Microb Drug Resist; 2006; 12(4):223-30. PubMed ID: 17227206
[TBL] [Abstract][Full Text] [Related]
15. Control strategies for carbapenemase-producing Enterobacteriaceae at different levels of the healthcare system.
Asensio Á; Cantero M; Shaw E; Vergara-López S
Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():61-6. PubMed ID: 25542054
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic options for carbapenemase-producing Enterobacteriaceae].
Salgado P; Gilsanz F; Maseda E
Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():12-5. PubMed ID: 26365727
[TBL] [Abstract][Full Text] [Related]
17. Over-treatment of carbapenemase-producing Enterobacteriaceae.
Rihani DS; Wallace MR; Sieger BE; Waite RA; Fox M; Brown SA; Deryke CA
Scand J Infect Dis; 2012 May; 44(5):325-9. PubMed ID: 22200121
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive clinical and epidemiological assessment of colonisation and infection due to carbapenemase-producing Enterobacteriaceae in Spain.
Palacios-Baena ZR; Oteo J; Conejo C; Larrosa MN; Bou G; Fernández-Martínez M; González-López JJ; Pintado V; Martínez-Martínez L; Merino M; Pomar V; Mora-Rillo M; Rivera MA; Oliver A; Ruiz-Carrascoso G; Ruiz-Garbajosa P; Zamorano L; Bautista V; Ortega A; Morales I; Pascual Á; Campos J; Rodríguez-Baño J;
J Infect; 2016 Feb; 72(2):152-60. PubMed ID: 26546855
[TBL] [Abstract][Full Text] [Related]
19. The challenges of carbapenemase-producing Enterobacteriaceae and infection prevention: protecting patients in the chaos.
Savard P; Carroll KC; Wilson LE; Perl TM
Infect Control Hosp Epidemiol; 2013 Jul; 34(7):730-9. PubMed ID: 23739078
[No Abstract] [Full Text] [Related]
20. Temocillin and piperacillin/tazobactam resistance by disc diffusion as antimicrobial surrogate markers for the detection of carbapenemase-producing Enterobacteriaceae in geographical areas with a high prevalence of OXA-48 producers.
Huang TD; Poirel L; Bogaerts P; Berhin C; Nordmann P; Glupczynski Y
J Antimicrob Chemother; 2014 Feb; 69(2):445-50. PubMed ID: 24055766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]